Its expression levels exhibit significant variation across different types of lung cancer; studies have demonstrated that elevated MUC4 expression is associated with adverse clinical outcomes in lung adenocarcinoma and lung squamous cell carcinoma. Here, MUC4 is linked to lung carcinoma.